Board Meetings for JAGSNPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
JAGSNPHARMJagsonpal Pharmaceuticals Limited27 Apr 2026Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2026 and dividend
JAGSNPHARMJagsonpal Pharmaceuticals Limited27 Apr 2026Board Meeting IntimationJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-Apr-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
JAGSNPHARMJagsonpal Pharmaceuticals Limited12 Mar 2026BuybackTo consider buyback for equity shares
JAGSNPHARMJagsonpal Pharmaceuticals Limited12 Mar 2026Board Meeting IntimationJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Mar-2026 to consider Buyback.
JAGSNPHARMJagsonpal Pharmaceuticals Limited21 Jan 2026Board Meeting IntimationJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 21-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
JAGSNPHARMJagsonpal Pharmaceuticals Limited21 Jan 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
JAGSNPHARMJagsonpal Pharmaceuticals Limited03 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
JAGSNPHARMJagsonpal Pharmaceuticals Limited03 Nov 2025Board Meeting IntimationJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .
JAGSNPHARMJagsonpal Pharmaceuticals Limited26 Jul 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
JAGSNPHARMJagsonpal Pharmaceuticals Limited26 Jul 2025Board Meeting IntimationJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 26-Jul-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .
JAGSNPHARMJagsonpal Pharmaceuticals Limited06 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend, if any
JAGSNPHARMJagsonpal Pharmaceuticals Limited06 May 2025Board Meeting IntimationJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend.
JAGSNPHARMJagsonpal Pharmaceuticals Limited22 Jan 2025Financial ResultsTo consider and approve the financial results for the period ended December 31, 2024
JAGSNPHARMJagsonpal Pharmaceuticals Limited22 Jan 2025Board Meeting IntimationJAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 22-Jan-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
JAGSNPHARMJagsonpal Pharmaceuticals Limited23 Oct 2024JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Stock split.Board Meeting Intimation
Showing page 1 of 8 (110 total items)
Next